The Trump administration, if it becomes more familiar with the Food and Drug Administration’s responsibilities and workload, may experience the same “confusion and uncertainty” cast over regulated industries by the recent cleaving of agency staff and a budget unchanged from the previous year.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?